Lid2 is a nuclear protein in S. pombe that acts as a trimethylated histone H3 lysine 4 (H3K4me3) demethylase. Key features include:
Domain Structure: Contains a JmjC domain critical for enzymatic activity, with conserved α-ketoglutarate (α-KG) and iron-binding sites required for demethylation .
Chromatin Association: Binds heterochromatic regions (e.g., centromeres, mating-type loci) and regulates H3K4/H3K9 methylation cross-talk .
Lid2 interacts with the Clr4-Rik1 complex to coordinate H3K9 methylation (a heterochromatin marker) and H3K4me3 demethylation:
Genetic Interaction: Deletion of Lid2’s JmjC domain abolishes H3K9 methylation and heterochromatic silencing (e.g., loss of ura4+ gene silencing) .
Enzymatic Activity: Overexpression reduces H3K4me3 levels by >80% (p < 0.001) .
| Mutation | H3K4me3 Level | H3K9me2/3 Level | Heterochromatin Silencing |
|---|---|---|---|
| lid2-j (JmjC Δ) | ↑↑ | ↓↓ | Lost |
| Lid2 overexpression | ↓↓↓ | ↔ | Enhanced |
Lid2 modulates H3K4 methylation in euchromatin by interacting with Set1 (H3K4 methyltransferase) and Lsd1 (demethylase), suggesting a dynamic regulatory network .
Key methodologies used to study Lid2 include:
Chromatin Immunoprecipitation (ChIP): Demonstrated Lid2 enrichment at heterochromatic regions .
Immunostaining/Western Blot: Confirmed H3K4me3 reduction upon Lid2 overexpression .
Co-Immunoprecipitation (Co-IP): Validated physical interactions with Clr4 and Rik1 .
While no commercial Lid2 antibodies are described in the provided sources, general principles for antibody validation (e.g., knockout controls, orthogonal assays) apply . For example:
Specificity Controls: Use of lid2Δ strains to confirm signal absence.
Functional Assays: Correlation of antibody reactivity with phenotypic outcomes (e.g., H3K4me3 levels).
Lid2’s role in bridging H3K4 demethylation and H3K9 methylation provides a model for understanding epigenetic coordination in eukaryotes. Future studies could explore:
Mechanistic Links: How Lid2’s enzymatic activity is spatiotemporally regulated.
Therapeutic Potential: Targeting histone demethylases in diseases linked to epigenetic dysregulation.
KEGG: spo:SPBP19A11.06
STRING: 4896.SPBP19A11.06.1